2022
DOI: 10.3390/jcm11071760
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Calbindin, a Marker of Gamma-Aminobutyric Acid Neurons, Is Reduced in the Amygdala of Oestrogen Receptor β-Deficient Female Mice

Abstract: Oestrogen receptor β (ERβ) knock-out female mice display increased anxiety and decreased threshold for synaptic plasticity induction in the basolateral amygdala. This may suggest that the γ-aminobutyric acid (GABA) inhibitory system is altered. Therefore, the immunoreactivity of main GABAergic markers—i.e., calbindin, parvalbumin, calretinin, somatostatin, α1 subunit-containing GABAA receptor and vesicular GABA transporter—were compared in the six subregions (LA, BL, BM, ME, CE and CO) of the amygdala of adult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 94 publications
0
1
0
Order By: Relevance
“…In order to investigate the influence of systemic inflammation in brain inflammation, we administered lipopolysaccharide (LPS) intraperitoneally to the S1 mouse to enhance systemic inflammation and investigated expression of neural differentiation markers in the olfactory bulb and brain. As a result, the expression of calbindin, 48 , 49 a GABAergic neuron marker, was markedly decreased. ( Figures 2 I and 2J).…”
Section: Resultsmentioning
confidence: 99%
“…In order to investigate the influence of systemic inflammation in brain inflammation, we administered lipopolysaccharide (LPS) intraperitoneally to the S1 mouse to enhance systemic inflammation and investigated expression of neural differentiation markers in the olfactory bulb and brain. As a result, the expression of calbindin, 48 , 49 a GABAergic neuron marker, was markedly decreased. ( Figures 2 I and 2J).…”
Section: Resultsmentioning
confidence: 99%
“…The men's preponderance in those forms of dystonia like ULD that mainly develop before menopause, and the women's preponderance in those forms of dystonia, like cranial dystonia, that mostly develop at around or after menopause, would suggest a protective role of oestrogens on dystonia development. Supporting this view, oestrogens have been proposed as a protective factor for GABAergic systems and the nigrostriatal dopaminergic system, [17][18][19] both implicated in developing animal models of dystonia. 20 21 If oestrogens contribute to developing at least some forms of IAOD, there may be a complex interaction between hormonal influences and putative environmental risk factors.…”
Section: Movement Disordersmentioning
confidence: 98%